You are here

Article Text

Article menu
Download PDFPDF
Case Reports: Rare disease
Peripartum cardiomyopathy: a rare cause of acute heart failure
  1. Tabea Cornelia Elisabeth Vogel1,
  2. Stephan Schneiter2 and
  3. Thomas Fehr1
  1. 1Department of Internal Medicine, Kantonsspital Graubunden, Chur, Switzerland
  2. 2Department of Internal Medicine, Cardiology, Kantonsspital Graubunden, Chur, Switzerland
  1. Correspondence to Professor Thomas Fehr; Thomas.fehr{at}ksgr.ch

Abstract

A woman in her early 30s presented herself with acute dyspnoea and elevated D-dimers 5 weeks after delivery of her second child. Echocardiographic findings showed signs of acute left ventricular failure, and an MRI confirmed a non-ischaemic dilated left heart failure compatible with peripartum cardiomyopathy. The antihormonal therapy with bromocriptine during 6 weeks and an intensive heart failure therapy led to an amelioration of the heart function within 3 years, but full recovery was not yet observed.

  • heart failure
  • obstetrics, gynaecology and fertility
  • pregnancy

https://doi.org/10.1136/bcr-2021-244821

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors TF: idea for the article, attending physician during inpatient care, theoretical supervision, text corrections. SS: specialist assessment during inpatient care, clinical follow-up and echocardiographic recording, text corrections. TCEV: attending physician during inpatient care, theoretical research, article writing, patient correspondance.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.